Back to Authors

Tremblay, Douglas

https://orcid.org/0000-0003-2584-6953

A5108039880 | I98704320

Mayo Clinic

Icahn School of Medicine at Mount Sinai

Citations 1

Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis

Leukemia & Lymphoma | January 23, 2019 | Volume: 60 | Issue: 5 | Pages: 1343-1345

10.1080/10428194.2018.1532509 | PMID 30668266